SYNDAX PHARMACEUTICALS INC's ticker is SNDX and the CUSIP is 87164F105. A total of 177 filers reported holding SYNDAX PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.88 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,328,565 | -76.2% | 91,499 | -65.7% | 0.01% | -75.8% |
| Q2 2023 | $5,590,026 | +45.1% | 267,082 | +46.4% | 0.03% | +37.5% |
| Q1 2023 | $3,851,887 | -15.5% | 182,381 | +1.8% | 0.02% | -20.0% |
| Q4 2022 | $4,557,713 | +175.7% | 179,085 | +160.3% | 0.03% | +172.7% |
| Q3 2022 | $1,653,000 | -58.5% | 68,803 | -66.7% | 0.01% | -57.7% |
| Q2 2022 | $3,979,000 | +9.1% | 206,818 | -1.4% | 0.03% | +30.0% |
| Q1 2022 | $3,647,000 | -17.0% | 209,835 | +4.5% | 0.02% | -13.0% |
| Q4 2021 | $4,396,000 | +12.7% | 200,842 | -1.6% | 0.02% | +9.5% |
| Q3 2021 | $3,902,000 | +10.3% | 204,181 | -0.9% | 0.02% | +10.5% |
| Q2 2021 | $3,537,000 | +29.0% | 206,001 | +68.0% | 0.02% | +26.7% |
| Q1 2021 | $2,742,000 | +11.8% | 122,640 | +11.2% | 0.02% | 0.0% |
| Q4 2020 | $2,453,000 | +200.6% | 110,309 | +99.5% | 0.02% | +200.0% |
| Q3 2020 | $816,000 | -20.8% | 55,289 | -20.4% | 0.01% | -28.6% |
| Q2 2020 | $1,030,000 | +35.3% | 69,475 | 0.0% | 0.01% | +40.0% |
| Q1 2020 | $761,000 | -34.1% | 69,475 | -47.2% | 0.01% | 0.0% |
| Q4 2019 | $1,154,000 | -26.5% | 131,479 | -37.4% | 0.01% | -28.6% |
| Q3 2019 | $1,570,000 | -14.9% | 210,156 | +6.0% | 0.01% | -12.5% |
| Q2 2019 | $1,845,000 | +137.1% | 198,170 | +33.8% | 0.01% | +166.7% |
| Q1 2019 | $778,000 | +9.1% | 148,140 | -7.6% | 0.00% | 0.0% |
| Q4 2018 | $713,000 | -43.6% | 160,295 | +2.4% | 0.00% | -40.0% |
| Q3 2018 | $1,265,000 | +106.4% | 156,513 | +79.1% | 0.01% | +150.0% |
| Q2 2018 | $613,000 | -23.5% | 87,383 | +55.3% | 0.00% | -33.3% |
| Q1 2018 | $801,000 | +12.8% | 56,258 | -30.6% | 0.00% | 0.0% |
| Q4 2017 | $710,000 | – | 81,056 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kynam Capital Management, LP | 3,600,000 | $52,272,000 | 8.55% |
| Foresite Capital Management IV, LLC | 875,000 | $12,705,000 | 7.06% |
| Aisling Capital Management LP | 1,025,000 | $14,883,000 | 6.13% |
| Saturn V Capital Management LP | 807,969 | $11,731,710 | 4.91% |
| Eversept Partners, LP | 2,596,245 | $37,697,477 | 3.19% |
| ACUTA CAPITAL PARTNERS, LLC | 297,035 | $4,312,948 | 2.89% |
| Paradigm Biocapital Advisors LP | 2,390,077 | $34,703,918 | 2.36% |
| DAFNA Capital Management LLC | 458,373 | $6,655,576 | 2.07% |
| SPHERA FUNDS MANAGEMENT LTD. | 773,061 | $11,224,846 | 2.04% |
| PFM Health Sciences, LP | 2,715,235 | $39,425,212 | 1.86% |